Joel Kantrowitz

580 total citations
11 papers, 354 citations indexed

About

Joel Kantrowitz is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Joel Kantrowitz has authored 11 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Joel Kantrowitz's work include Cardiac electrophysiology and arrhythmias (5 papers), Cardiac Arrhythmias and Treatments (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Joel Kantrowitz is often cited by papers focused on Cardiac electrophysiology and arrhythmias (5 papers), Cardiac Arrhythmias and Treatments (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Joel Kantrowitz collaborates with scholars based in United States, Canada and Belgium. Joel Kantrowitz's co-authors include A. Donald Finck, George J. Cardinale, Josef Donnerer, Sydney Spector, James K. Hennan, John A. Butera, Robert E. Swillo, Hal S. Feldman, Ketil Haugan and Samuel Davis and has published in prestigious journals such as Circulation, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Joel Kantrowitz

10 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel Kantrowitz United States 6 178 94 88 87 53 11 354
Eman Rashed United States 10 239 1.3× 86 0.9× 6 0.1× 38 0.4× 23 0.4× 22 376
Joachim Günther Germany 9 171 1.0× 253 2.7× 15 0.2× 19 0.2× 56 1.1× 16 417
Sarah Hamren United States 9 170 1.0× 96 1.0× 33 0.4× 54 0.6× 126 2.4× 10 425
Sandhya Sanghi United States 6 149 0.8× 131 1.4× 23 0.3× 27 0.3× 22 0.4× 8 327
Ziqian Xu China 12 40 0.2× 167 1.8× 141 1.6× 12 0.1× 11 0.2× 36 358
Sangita P. Patel United States 12 398 2.2× 289 3.1× 148 1.7× 25 0.3× 128 2.4× 40 597
Alexander Hajduczok United States 8 198 1.1× 79 0.8× 45 0.5× 15 0.2× 115 2.2× 27 334
C. Winkler Germany 8 66 0.4× 33 0.4× 21 0.2× 34 0.4× 29 0.5× 23 334
Adolfo Quiñones‐Lombraña United States 10 103 0.6× 30 0.3× 9 0.1× 46 0.5× 45 0.8× 18 275
Khiem Nguyen United States 11 132 0.7× 159 1.7× 53 0.6× 22 0.3× 8 0.2× 19 433

Countries citing papers authored by Joel Kantrowitz

Since Specialization
Citations

This map shows the geographic impact of Joel Kantrowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Kantrowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Kantrowitz more than expected).

Fields of papers citing papers by Joel Kantrowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Kantrowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Kantrowitz. The network helps show where Joel Kantrowitz may publish in the future.

Co-authorship network of co-authors of Joel Kantrowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Kantrowitz. A scholar is included among the top collaborators of Joel Kantrowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Kantrowitz. Joel Kantrowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Josowitz, Alexander, Marc Pelletier, Samuel H. Jennings, et al.. (2025). Feasibility and pharmacokinetic evaluation of a needle‐free injector for delivering high concentration antibody formulations. Bioengineering & Translational Medicine.
2.
Al‐Huniti, Nidal, John D. Davis, Alina Baum, et al.. (2022). A drug‐disease model for predicting survival in an Ebola outbreak. Clinical and Translational Science. 15(10). 2538–2550. 5 indexed citations
3.
Sivapalasingam, Sumathi, George A. Saviolakis, Kirsten Kulcsar, et al.. (2021). Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus. The Journal of Infectious Diseases. 225(10). 1765–1772. 3 indexed citations
4.
Smith, Eric, Kara Olson, Lauric Haber, et al.. (2015). A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys. Scientific Reports. 5(1). 17943–17943. 122 indexed citations
5.
Rossman, Eric I., Kun Liu, Robert E. Swillo, et al.. (2009). The Gap Junction Modifier, GAP-134 [(2S,4R)-1-(2-Aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic Acid], Improves Conduction and Reduces Atrial Fibrillation/Flutter in the Canine Sterile Pericarditis Model. Journal of Pharmacology and Experimental Therapeutics. 329(3). 1127–1133. 48 indexed citations
6.
Hennan, James K., Robert E. Swillo, Eric I. Rossman, et al.. (2009). GAP-134 ([2S,4R]-1-[2-Aminoacetyl]4-Benzamidopyrrolidine-2-Carboxylic Acid) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs. Journal of Cardiovascular Pharmacology and Therapeutics. 14(3). 207–214. 20 indexed citations
7.
Rossman, Eric I., Kun Liu, Robert E. Swillo, et al.. (2007). Abstract 1837: Effects of the Gap Junction Modifier, GAP-134, on Conduction and Atrial Fibrillation/Flutter Inducibility in Dogs. Circulation. 116(suppl_16). 1 indexed citations
8.
Hennan, James K., Robert E. Swillo, James C. Keith, et al.. (2006). Rotigaptide (ZP123) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs. Journal of Pharmacology and Experimental Therapeutics. 317(1). 236–243. 71 indexed citations
9.
Hennan, James K., Hal S. Feldman, Robert E. Swillo, et al.. (2005). ZP123 Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs. 4 indexed citations
10.
Dodion, P., Dominique de Valeriola, Joel Kantrowitz, et al.. (1991). Phase I clinical and pharmacokinetic study of zeniplatin, a new platinum complex. Annals of Oncology. 2(8). 589–596. 11 indexed citations
11.
Cardinale, George J., et al.. (1987). Morphine and codeine are endogenous components of human cerebrospinal fluid. Life Sciences. 40(3). 301–306. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eman Rashed Breakdown of academic impact, for papers by Joachim Günther Breakdown of academic impact, for papers by Sarah Hamren Breakdown of academic impact, for papers by Sandhya Sanghi Breakdown of academic impact, for papers by Ziqian Xu Breakdown of academic impact, for papers by Sangita P. Patel Breakdown of academic impact, for papers by Alexander Hajduczok Breakdown of academic impact, for papers by C. Winkler Breakdown of academic impact, for papers by Adolfo Quiñones‐Lombraña Breakdown of academic impact, for papers by Khiem Nguyen
Rankless by CCL
2026